FDA approves new drug for severe drooling
On July 28, the U.S. Food and Drug Administration (FDA) approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling…
RECENT POSTS
- Caring for diverse patient populations in their homes June 29, 2022
- Magnet® and COVID-19 response June 26, 2022
- Operationalizing the Pathway to Excellence® quality standard June 26, 2022
- ANA Statement on overturn of Roe vs. Wade June 24, 2022
- Do Vitamins, Plants Help Uterine Fibroid Risk or Treatment? June 23, 2022